 |
인쇄하기
취소
|
Drug makers to face uphill battle over drug pricing
A report, released by the Health Insurance Review Assessment and Service on April 6, will mostly affect the revenue of pharmaceutical firms that sell antihypertensive drugs.
Based on the previous report of Professor Kim Jin-hyun last February, the HIRAS report stated that the government agency will evaluate all of antihypertensive medicines in terms of clinical efficacy and economic effectiv...
Based on the previous report of Professor Kim Jin-hyun last February, the HIRAS report stated that the government agency will evaluate all of antihypertensive medicines in terms of clinical efficacy and economic effectiv...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.